Long-term effects of systemic gene therapy in a canine model of myotubular myopathy - Université d'Évry Access content directly
Journal Articles Muscle & nerve. Supplement. Year : 2017

Long-term effects of systemic gene therapy in a canine model of myotubular myopathy

Abstract

X-linked myotubular myopathy (XLMTM), a devastating pediatric disease caused by the absence of the protein myotubularin, results from mutations in the MTM1 gene. While there is no cure for XLMTM, we previously reported effects of MTM1 gene therapy using adeno-associated virus (AAV) vector on muscle weakness and pathology in MTM1-mutant dogs. Here, we followed 2 AAV-infused dogs over 4 years.

Dates and versions

hal-02179358 , version 1 (10-07-2019)

Identifiers

Cite

Matthew Elverman, Melissa Goddard, David Mack, Jessica Snyder, Michael Lawlor, et al.. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. Muscle & nerve. Supplement., 2017, 56 (5), pp.943-953. ⟨10.1002/mus.25658⟩. ⟨hal-02179358⟩
52 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More